CNO Form 4: Karen DeToro Sells 25,657 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Karen J. DeToro, President of the Worksite Division at CNO Financial Group (CNO), reported sales of common stock under a Rule 10b5-1 plan adopted May 6, 2025. The filing shows three separate dispositions on August 13-15, 2025 totaling 25,657 shares sold at weighted average prices of approximately $37.96, with reported per-trade weighted averages of $37.9588, $37.9788 and $37.8481. After these sales the reporting person beneficially owned 41,855 shares. The filing indicates the transactions were made pursuant to an affirmative-defense 10b5-1 plan and that detailed per-price breakdowns can be provided upon request.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider disposed of 25,657 shares via a 10b5-1 plan, reducing holdings to 41,855 shares; disclosure consistent with planned sales.
The report documents systematic sales under a Rule 10b5-1 plan adopted May 6, 2025, which signals pre-arranged dispositions rather than opportunistic trading. Totals and weighted average prices are provided for three sequential trading dates (08/13/2025–08/15/2025). From a governance perspective, use of a 10b5-1 plan enhances procedural defensibility; the filing also offers to provide per-price sale breakdowns if requested, supporting transparency.
TL;DR: Reported sales of 25,657 shares at ~ $37.8–$38.2 under a 10b5-1 plan leave the insider with 41,855 shares.
Three sales occurred: 9,920 shares on 08/13/2025, 6,509 shares on 08/14/2025 and 9,228 shares on 08/15/2025. The filing lists weighted average sale prices and ranges for each date and confirms the transactions were dispositions (code S). The disclosure is factual and limited to share counts and prices; no derivative or other transactions are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 9,228 | $37.8481 | $349K |
| Sale | Common Stock | 6,509 | $37.9788 | $247K |
| Sale | Common Stock | 9,920 | $37.9588 | $377K |
Footnotes (1)
- Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 6, 2025. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.82 per share to $38.17 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.79 per share to $38.17 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.68 per share to $38.24 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.